An Indirect Competitive Enzyme-linked Immunosorbent Assay for Simultaneous Determination of Florfenicol and Thiamphenicol in Animal Meat and Urine

A high-affinity polyclonal antibody was prepared by immunizing animals with haptens FFD and FFM. Under the optimal combination of coating antigen and antibody, an indirect competitive enzyme-linked immunosorbent assay (icELISA) for simultaneous detection of florfenicol and thiamphenicol residues in animal meat and urine samples was developed. The icELISA showed an IC₅₀ value of 1.32 ng mL^?1 for florfenicol and 2.13 ng mL^?1 for thiamphenicol, respectively. The linear ranges were from 0.31 to 5.61 ng mL^?1 with a limit of detection of 0.12 ng mL^?1 for florfenicol, and 0.41 to 11.2 ng mL^?1 with a limit of detection of 0.15 ng mL^?1 for thiamphenicol, respectively. The average recoveries of florfenicol and thiamphenicol in spiked samples ranged from 77.2% to 116.0% with a relative standard deviation of less than 15%. Therefore, this proposed icELISA provided a valid detection method for florfenicol and thiamphenicol residues in animal tissue and urine samples.     

Polarography of disodium pentacyanonitrosylferrate(II): Part 2. Determination at Therapeutic Levels in Serum,Plasma, and Whole Blood

Disodium pentacyanonitrosylferrat(II) (sodium nitroprusside) is determined at therapeutic (ng ml^?1) levels in plasma, serum and blood with conventional and high-performance differential pulse polarography (d.p.p. and h.p.d.p.p.) at a dropping mercury electrode or a static mercury drop electrode. Serum or plasma (3 ml) is treated with perchloric acid containing 1 mg ml^?1 potassium hexacyanoferrate(II), centrifuged for 10 min and subjected to polarography. For spiked serum, calibration graphs are linear over the range 30–1000 ng ml^?1 sodium nitroprusside, regardless of the polarographic technique; the estimated detection limit is 15 ng ml^?1 (5 × 10^?8 M). Calculated therapeutic levels range from 100 to 1000 ng ml^?1. Similar results were obtained for spiked plasma. A similar procedure is suitable for whole blood and was used to study the in-vitro degradation of sodium nitroprusside (200 ng ml^?1) on incubation at 37°C. The in-vitro loss is rapid (t_{$\text{1}\text{2}$} ≈ 6 min) but meaningful in-vivo levels can be obtained when the blood is collected in a 0.9% sodium chloride solution at 0°C. Thiocyanate, the main metabolite of nitroprusside, and thiosulphate, which is a potential antidote for cyanide, do not interfere.     

LC Determination of Ketorolac in Human Plasma and Urine for Application to Pharmacokinetic Studies

A simple, specific and sensitive liquid chromatographic method has been developed for the assay of ketorolac in human plasma and urine. The clean-up of plasma and urine samples were carried out by protein precipitation procedure and liquid–liquid extraction, respectively. Separation was performed by a Waters sunfire C₁₈ reversed-phase column maintained at 35 °C. The mobile phase was a mixture of 0.02 M phosphate buffer (pH adjusted to 4.5 for plasma samples and to 3.5 for urine samples) and acetonitrile (70:30, v/v) at a flow rate of 1.0 mL min^?1. The UV detector was set at 315 nm. Nevirapine was used as an internal standard in the assay of urine sample. The method was validated over the concentration range of 0.05–8 and 0.1–10 μg mL^?1 for ketorolac in human plasma and urine, respectively. The limits of detection were 0.02 and 0.04 μg mL^?1 for plasma and urine estimation at a signal-to-noise ratio of 3. The limits of quantification were 0.05 and 0.1 μg mL^?1 for plasma and urine, respectively. The extraction recoveries were found to be 99.3 ± 4.2 and 80.3 ± 3.7% for plasma and urine, respectively. The intra-day and inter-day standard deviations were less than 0.5. The method indicated good performance in terms of specificity, linearity, detection and quantification limits, precision and accuracy. This assay demonstrated to be applicable for clinical pharmacokinetic studies.     

Analysis of dextromethorphan and pseudoephedrine in human plasma and urine samples using hollow fiber-based liquid–liquid–liquid microextraction and corona discharge ion mobility spectrometry

We report on the use of hollow fiber liquid-liquid-liquid microextraction (HF-LLLME) followed by corona discharge ion mobility spectrometry for the determination of dextromethorphan and pseudoephedrine in urine and plasma samples. The effects of pH of the donor phase, stirring rate, ionic strength and extraction time on HF-LLLME were optimized. Under the optimized conditions, the linear range of the calibration curves for dextromethorphan in plasma and urine, respectively, are from 1.5 to 150 and from 1 to 100 ng mL^?1. The ranges for pseudoephedrine, in turn, are from 30 to 300 and from 20 to 200 ng mL^?1. Correlation coefficients are better than 0.9903. The limits of detection are 0.6 and 0.3 ng mL^?1 for dextromethorphan, and 8.6 and 4.2 ng mL^?1 for pseudoephedrine in plasma and urine samples, respectively. The relative standard deviations range from 6 to 8%.

Enantioselective Analysis of Amphetamine-Related Designer Drugs in Body Fluids Using Liquid Chromatography and Solid-Phase Derivatization

A method for the enantioselective determination of the amphetamine-derived designer drugs 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxyethylamphetamine (MDE) based on their derivatization with (-)-1-(9-fluorenyl)ethyl chloroformate (FLEC) is described. The proposed procedure entails preconcentration and derivatization of the analytes into C₁₈-packed solid-phase extraction cartridges, chromatographic separation of the diastereomers originated in a C₁₈ column under gradient elution, and UV detection at 265 nm. Compared with the solution derivatization approach the described procedure increased analyte responses by factors of 28–58. The reliability of the method has been tested by analysing plasma and urine samples spiked with the analytes in the 0.015–1.0 μg mL^?1 concentration interval. The proposed conditions provided adequate linearity, and coefficients of variation ranging from 5% to 14% in plasma, and from 3% to 12% in urine. The recoveries of the analytes were of 78%–126% and 78%–128% in plasma and urine, respectively. The limits of detection (LODs) obtained for all the analytes were 5 ng mL^?1 in both biological matrices.     

High-performance liquid chromatographic determination of the antitumor agent mitomycin c in human blood plasma

A high-performance liquid chromatographic method for the determination of the antitumor drug mitomycin C in blood plasma samples of cancer patients is described. The drug is extracted from the plasma with chloroform–2-propanol (1+1, $\text{w}\text{w}$) and chromatographed on a reversed-phase column with u.v. detection at 365 nm. The detection limit of the determination is 1 ng ml^-1 for 0.2–1.0 ml plasma samples. Preliminary results of a pharmacokinetic study show that the sensitivity and selectivity of the assay are adequate for drug monitoring in clinical practice. The results obtained from multiwavelength detection suggest the existence of metabolites.     

Determination of furazolidone in urine by square-wave voltammetric method

A fast, simple and sensitive square-wave voltammetric (SWV) method for the determination of trace amounts of furazolidone (FZ) in urine is reported. A three-electrode system containing stationary mercury dropping (SMDE) working electrode, Pt auxiliary electrode and Ag/AgCl reference electrode was used throughout. Briton-Rabinson buffer solution is used as both pH adjusting agent and supporting electrolyte. The calibration graph showed good linearity in the concentration range of 20–900 ng ml^?1 of furazolidone with a regression coefficient of 0.9996. The equation Δ(i) = 0.0095C_FZ + 0.234 was used for calculation of furazolidone concentration in the sample solution, where C_FZ is the concentration of furazolidone in ng ml^?1 and Δ(i) is the difference between voltammogram peak currents of sample and blank solution. The RSD for 8 replicate measurements of a 60 ng ml^?1 solution and LOD of the proposed method were found to be 2.2% and 5.2 ng ml^?1, respectively. The procedure was successfully applied to the determination of furazolidone in urine samples.     

Determination of Mercury in Urine and Seawater by Flow Injection Vapor Generation Isotope Dilution Inductively Coupled Plasma Mass Spectrometry

A simple and inexpensive laboratory-built vapor generator was used with inductively coupled plasma mass spectrometry (ICP-MS) for the determination of mercury in urine and seawater samples. The applications of vapor generation ICP-MS alleviated the non-spectroscopic interferences and the sensitivity problem of mercury determination encountered when the conventional pneumatic nebulizer was used for sample introduction. The concentration of mercury was determined by isotope dilution method. The isotope ratio of mercury was calculated from the peak areas of each injection peak. The repeatability of the peak areas and isotope ratio determinations of seven consecutive injections of 1 ng mL^?1 Hg solution were 2.3% and 2.2%, respectively. This method has a detection limit of 0.07 ng mL^?1 for mercury. This method was applied to determine mercury in a CASS-3 nearshore seawater reference sample, NASS-4 open ocean seawater reference sample, NIST SRM 2670 freeze-dried urine reference sample and several urine and seawater samples collected from National Sun Yat-Sen University. The results for the reference samples agreed satisfactorily with the reference values. Results for other samples analyzed by the isotope dilution method and the method of standard additions agreed satisfactorily. Precision was better than 10% for most of the determinations.     

Porous carbon derived from a metal–organic framework as an efficient adsorbent for the solid‐phase extraction of phthalate esters

A porous carbon designated as MOF‐5‐C was prepared by directly carbonizing a metal–organic framework (MOF‐5). The morphology and microstructure of MOF‐5‐C were characterized by scanning electron microscopy, N₂ adsorption, and powder X‐ray diffraction. The MOF‐5‐C retained the original porous structures of MOF‐5, and showed a high Brunauer–Emmett–Teller surface area (1808 m² g^?1) and large pore volume (3.05 cm³ g^?1). To evaluate its adsorption performance, the MOF‐5‐C was used as an adsorbent for the solid‐phase extraction of four phthalate esters from bottled water, peach juice, and soft drink samples followed by high‐performance liquid chromatographic analysis. Several parameters that could affect the extraction efficiencies were investigated. Under the optimum conditions, a good linearity was achieved in the concentration range of 0.1–50.0 ng mL^?1 for bottled water sample and 0.2–50.0 ng mL^?1 for peach juice and soft drink samples. The limits of detection of the method (S/N = 3) were 0.02 ng mL^?1 for bottled water sample, and 0.04–0.05 ng mL^?1 for peach juice and soft drink samples. The results indicated that the MOF‐5‐C exhibited an excellent adsorption capability for trace levels of phthalate esters, and it could be a promising adsorbent for the preconcentration of other organic compounds.     

Trace determination of nickel by microwave-induced plasma atomic emission spectrometry after preconcentration of nickel tetracarbonyl on Chromosorb

A method is presented for the determination of ultra-trace nickel concentrations in various samples. Ni²⁺ is reduced in aqueous solution by tetrahydroborate to Ni⁰, which reacts readily with carbon monoxide to give gaseous Ni(CO)₄, the latter being preconcentrated on Chromosorb, cooled by liquid nitrogen. After desorption of the carbonyl by electrically heating the Chromosorb trap, it is swept by argon to the microwave-induced plasma (hollow-cylinder O₂-Ar MIP with Beenakker resonator). Using this technique, nickel detection is possible without any interferences, because other carbonyl-forming reactions are too slow. The detection limit is 5 pg (3σ), corresponding to 5 ng l^?1, and the relative standard deviation is 3% at 100 pg. The method was applied to sea water and urine without digestion and whole blood, blood serum and human hair after decomposition by HNO₃-HClO₄.     

λ-radiolysis of mitomycin c derivatives

The λ-Radiolysis reactions of mitomycin C ( 1 ) and its derivatives were studied in the hope of developing a radiation-induced drug (RID). The λ-radiolysis reactions were carried out in aqueous solutions under the condition where hydrated electron (e^?_aq) was generated as a principal reactive species. The competitive λ-radiolysis studies revealed that the rate constants for the reactions of 1 with e^?_aq at room temperature was 3.6 × 10¹⁰ dm³ mol^?1s^?1. Among mitomycin C derivatives, the 5H-6-alkoxyimino derivatives 11 and 12 , and compound 13 in which ring A of 1 has the 4-hydroxy-6-hydroxyimino structure cleaved to give 1 . The mechanic aspect of these λ-radiolysis reactions is discussed.     

Synthesis of derivatives and production of antiserum for class specific detection of pyrethroids by indirect ELISA

Two series of haptens including 3-phenoxybenzoic acid (PBA) and 3-(2-chloro-3, 3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclo-propanecarboxylic acid (CF₃MPA) were used to prepare immunogens through attachment of 4-C or 6-C handles. Class selective antibodies were produced by immunising rabbits. Ab502 showed the highest reactivity towards tau-fluvalinate (IC₅₀ 1.3 ng mL^?1), λ-cyhalothrin (IC₅₀ 2.3 ng mL^?1), cyfluthrin (IC₅₀ 2.2 ng mL^?1) and fenpropathrin (IC₅₀ 18.5 ng mL^?1) among the antibodies in a competitive ELISA. The effects of methanol, pH and salt concentration were optimised for maximum efficiency of the ELISA (Enzyme-Linked ImmunoSorbent Assay). Ab502 (1:80000)/2-OVA-1(0.2 µg mL^?1) was chosen for ELISA optimisation. Finally, 0.05 M phosphate buffered saline (PBS) at pH 6.5 containing 30% methanol (v/v) was used to dilute the standards. Target analytes in honey samples were extracted with ethyl acetate by sonication. The samples were spiked with three different concentrations of each compound (tau-fluvalinate, 0.5 ng g^?1, 3 ng g^?1, 12 ng g^?1; λ-cyhalothrin and cyfluthrin 1 ng g^?1, 5 ng g^?1, 65 ng g^?1). The recoveries were 36–59% at the lowest spiking concentration and 61–81% at the higher concentration. This assay might be useful to screen pyrethroid residues in honey or other matrix.     

Determination of Propylene Glycol in Low Volume Plasma and Urine Samples of Neonates by LC with Photodiode Array Detection

In order to enhance the sensitivity and to develop a method suitable for quantification of propylene glycol (PG) in low volume neonate plasma and urine samples, several steps in earlier described high performance liquid chromatographic methods were optimised. Chromatographic separation on a reversed-phase column and ultraviolet detection resulted in cleaner chromatograms without interfering compounds. Linearity of the standard curves was validated in the concentration range 0.25?C50 mg L^?1. The lower limit of quantification was 20 times lower than in earlier described methods. Presented method was suitable for quantification of PG concentrations in low volume neonate plasma (15?C46 mg L^?1) and urine samples (20?C175 mg L^?1) enabling us to document very low renal versus non-renal contribution of PG clearance in neonates.     

Fabrication of Immunosensor Based on Polyaniline,Fullerene‐C60 and Palladium Nanoparticles Nanocomposite: An Electrochemical Detection Tool for Prostate Cancer

Present work demonstrates the fabrication of new and facile sandwich‐type electrochemical immunosensor based on palladium nanoparticles (PdNPs), polyaniline (PANI) and fullerene‐C₆₀ nanocomposite film modified glassy carbon electrode (PdNP@PANI‐C₆₀/GCE) for ultrasensitive detection of Prostate‐specific antigen (PSA) biomarker. PdNP@PANI‐C₆₀ was electrochemically synthesized on GCE and used as an electroactive substrate. PdNP@PANI‐C₆₀ was characterized by scanning electron microscopy (SEM), energy‐dispersive X‐ray spectroscopy (EDS), cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). Primary antibody anti‐PSA (Ab1) was covalently immobilized on PdNP@PANI‐C₆₀/GCE using NHS/EDC linkers. In the presence of PSA antigen, horseradish peroxidase secondary antibody (HRP‐Ab2) was brought into the surface of the electrode, developing stable amplified signals of H₂O₂ reduction. Under the optimal conditions, a linear curve for determination of PSA at the proposed immunosensor was 1.6×10^?4 ng.mL^?1 to 38 ng.mL^?1 with a limit of detection (LOD) of 1.95×10^?5 ng.mL^?1. The proposed immunosensor was successfully validated in serum and urine samples towards PSA detection with satisfactory and acceptable results.     

Simple extraction of phencyclidine from human body fluids by headspace solid-phase microextraction (SPME)

Summary Phencyclidine (PCP) was found to be extractable by headspace solid-phase microextraction (SPME) from human whole blood and urine. Sample solutions were heated at 90°C in the presence of NaOH and K₂CO₃, and an SPME fiber was exposed in the headspace of a vial for 30 min. Immediately after withdrawal of the fiber, it was analyzed by gas chromatography with surface ionization detection (GC-SID). Recoveries of PCP were approximately 9.3–10.8% and 39.8–47.8% for whole blood and urine samples, respectively. The calibration curve for PCP showed good linearity in the range 2.5–100 ng mL^–1 whole blood and 0.5–100 ng mL^–1 urine. The detection limits were approximately 1.0 ng mL^–1 for whole blood and 0.25 ng mL^–1 for urine.     

Determination of four thiophenethylamine designer drugs (2C‐T‐4, 2C‐T‐8, 2C‐T‐13, 2C‐T‐17) in human urine by capillary electrophoresis/mass spectrometry

An analytical procedure for the simultaneous determination in human urine of four thiophenethylamine designer drugs (2C‐T series) is reported. The quantitative analysis was performed by capillary electrophoresis with mass spectrometric detection (CE/MS), using 2,5‐dimethoxy‐4‐methylthiophenethylamine‐D₄ (2C‐T‐D₄) as internal standard. In order to minimize interferences with matrix components and to preconcentrate target analytes, solid‐phase extraction (SPE) was introduced in the method as a clean‐up step. The method was validated according to international guidelines. The data for accuracy and precision were within required limits. Calibration curves were generated over the range from 10 to 500 ng mL^?1 and correlation coefficients always exceeded 0.997. The method was demonstrated to be specific, sensitive, and reliable for the analysis of these derivatives in urine samples. Copyright © 2010 John Wiley & Sons, Ltd.     

Rapid Determination of Meropenem in Biological Fluids by LC: Comparison of Various Methods for Sample Preparation and Investigation of Meropenem Stability

A rapid and sensitive LC-UV method was developed and validated for the determination of meropenem, in human plasma and urine. Meropenem retention time was 4.8 min. Method development was based on comparative analysis of different extraction methods published as well as careful study of meropenem stability in biological samples under different conditions. Best results in plasma sample preparation were obtained from protein precipitation with methanol. LOQ was 0.1 µg mL^?1 for plasma and 1 µg mL^?1 for urine samples. Meropenem in plasma has low stability at room temperature (<20% of original content after 12 h), but had acceptable stability when the whole analysis procedure was designed to minimize the exposure of meropenem-containing samples and solutions to temperatures higher than 4 °C. The developed method was applied to a human pharmacokinetic study in patients with acute peritonitis.     

Pyrocatechol-1-Aldehyde 2-Benzothiazolylhydrazone As Reagent for the Spectrofluorimetric Determination of Nanogram Amounts of Gallium in Urine and Blood Serum

Abstract

A method is developed for the spectrofluorimetric determination of 1–80 ng.ml^?1 of gallium with pyrocatechol-1-aldehyde 2-benzothiazolylhydrazone, in a 50% (v/v) DMSO-Water medium at apparent pH 4.0 (monochloracetic/monochloracetate buffer). Λ_ex = 400nm, Λ_em = 504 nm (corrected). Interferences have been evaluated and the method applied to the determination of gallium in human urine and blood serum samples.     

Potentiometric detection in UPLC as an easy alternative to determine cocaine in biological samples

The analytical methods which are often used for the determination of cocaine in complex biological matrices are a prescreening immunoassay and confirmation by chromatography combined with mass spectrometry. We suggest an ultra‐high‐pressure liquid chromatography combined with a potentiometric detector, as a fast and practical method to detect and quantify cocaine in biological samples. An adsorption/desorption model was used to investigate the usefulness of the potentiometric detector to determine cocaine in complex matrices. Detection limits of 6.3 ng mL^?1 were obtained in plasma and urine, which is below the maximum residue limit (MRL) of 25 ng mL^?1. A set of seven plasma samples and 10 urine samples were classified identically by both methods as exceeding the MRL or being inferior to it. The results obtained with the UPLC/potentiometric detection method were compared with the results obtained with the UPLC/MS method for samples spiked with varying cocaine concentrations. The intraclass correlation coefficient was 0.997 for serum (n =7) and 0.977 for urine (n =8). As liquid chromatography is an established technique, and as potentiometry is very simple and cost‐effective in terms of equipment, we believe that this method is potentially easy, inexpensive, fast and reliable. Copyright © 2014 John Wiley & Sons, Ltd.     

On-line packed magnetic in-tube solid phase microextraction of acidic drugs such as naproxen and indomethacin by using Fe<Subscript>3</Subscript>O<Subscript>4</Subscript>@SiO<Subscript>2</Subscript>@layered double hydroxide nanoparticles with high anion exchange capacity

The authors describe a 3-component nanoparticle system composed of a silica-coated magnetite (Fe₃O₄) core and a layered double (Cu-Cr) hydroxide nanoplatelet shell. The sorbent has a high anion exchange capacity for extraction anionic species. A simple online system, referred to as "on-line packed magnetic-in-tube solid phase microextraction" was designed. The nanoparticles were placed in a stainless steel cartridge via dry packing. The cartridge was then applied to the preconcentration acidic drugs including naproxen and indomethacin from urine and plasma. Extraction and desorption times, pH values of the sample solution and flow rates of sample solution and eluent were optimized. Analytes were then quantified by HPLC with UV detection. Under optimal conditions, the limits of detection range from 70 to 800 ng L^?1, with linear responses from 0.1–500 μg L^?1 (water samples), 0.6–500 μg L^?1 (spiked urine), and 0.9–500 μg L^?1 (spiked plasma). The inter- and intra-assay precisions (RSDs, for n?=?5) are in the range of 2.2–5.4%, 2.8–4.9%, and 2.0–5.2% at concentration levels of 5, 25 and 50 μg L^?1, respectively. The method was applied to the analysis of the drugs in spiked human urine and plasma, and good results were achieved.

Open image in new window

Graphical abstract Fe₃O₄@SiO₂@CuCr-LDH magnetic nanoparticles were synthesized and packed in to a stainless steel column. The column was applied to solid phase microextraction of acidic drugs from biological samples.